Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980964 · ClinicalTrials.gov registry record · NA
Evaluation of NMES for Reducing Pain and Improving Functional Outcomes in Knee OA Patients
A NA study, sponsored by CyMedica Orthopedics.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03980964: Completed NA study, sponsored by CyMedica Orthopedics.
NCT03980964 is a NA study that has completed, run by CyMedica Orthopedics. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03980964, a NA study, has completed, sponsored by CyMedica Orthopedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The present prospective trial is designed to evaluate the efficacy of CyMedica Orthopedics e-vive™ system, a multifunctional electrotherapy device providing neuromuscular electrical stimulation (NMES) for reducing pain and accelerating functional recovery in patients with knee osteoarthritis. This post-market trial will involve patients who have been diagnosed with knee osteoarthritis, Kelgren-Lawrence Grades II, III, and IV. It is hypothesized that the use of the CyMedica e-vive NMES can reduce pain, improve knee function, and improve quality of life.
Primary Outcome
Pain for a nominated activity causing the worst knee pain
Interventions
- DEVICE Active NMES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-06-07 |
| Est. Completion | 2021-04-16 |
| Phase | NA |
What the finished NCT03980964 record still lists
NCT03980964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Active NMES is the first listed.
NCT03980964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03980964 about?
NCT03980964 is a clinical study titled "Evaluation of NMES for Reducing Pain and Improving Functional Outcomes in Knee OA Patients". The present prospective trial is designed to evaluate the efficacy of CyMedica Orthopedics e-vive™ system, a multifunctional electrotherapy device providing neuromuscular electrical stimulation (NMES) for reducing pain and accelerating functional recovery in patients with knee osteoarthritis. This p...
What is the current status of trial NCT03980964?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-06-07. Estimated completion is 2021-04-16.
What interventions are being tested in trial NCT03980964?
The interventions under investigation include: Active NMES (DEVICE).
Who is sponsoring clinical trial NCT03980964?
This trial is sponsored by CyMedica Orthopedics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03980964's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI